{
  "id": 11230259,
  "title": "Sanofi, Regeneron broaden alliance to find their next Dupixent",
  "url": "https://urgent.news/2026/10/01/sanofi-regeneron-broaden-alliance-to-find-their-next-dupixent",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-01T15:38:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/sanofi-regeneron-alliance-expanded-dupixent-immunology-drugs-development/831894/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The deal carries a $1 billion upfront payment and tasks the two companies to develop long-acting antibody drugs that go after the same targets as their blockbuster anti-inflammation agent.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Regeneron, Sanofi expand alliance with $1 billion upfront deal",
        "url": "https://urgent.news/2026/10/01/regeneron-sanofi-expand-alliance-with-1-billion-upfront-deal",
        "published": "2026-10-01T05:04:36.000Z"
      },
      {
        "outlet": "Endpoints News",
        "title": "Sanofi builds on immunology alliance with Regeneron for $1B upfront",
        "url": "https://urgent.news/2026/10/01/sanofi-builds-on-immunology-alliance-with-regeneron-for-1b-upfront",
        "published": "2026-10-01T09:53:38.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}